Private investors: FCPI

Investing in innovative SMEs, supporting growth and employment

Channel individual savings into innovative start-ups

  • FCPI (funds dedicated to innovative companies) are funds approved by the AMF that allow individual investors to invest in up-and-coming and innovative unlisted companies.

Invest in technology and life sciences

  • Omnes Capital Venture Capital team manages €700 million in assets under management. For over 20 years, it has successfully supported dynamic and innovative companies in the digital and health sectors.

Benefit from tax incentives

  • Reduces your income tax by an amount equivalent to 18% of your investment (excl. entry charges) up to €2,160 for a single individual (for a maximum investment excl. entry charges of €12,000) or up to €4,320 for a married couple (for an investment of €24,000 excl. entry charges).
    For an investment of €10,000, the incentive works out at 10,000 x 18%, i.e. €1,800
  • In return for blocking assets over a period of 8 years, extendable by 1 year by decision of the management company
FCPI managed by Omnes Capital

Net asset values of Omnes Capital FCPI
> Download the document (French only)

 

The performance of a private equity fund is appreciated over a long investment period. The Net Asset Value may not reflect the potential of the portfolio assets over the life of the Fund and may not reflect the potential evolution of their fair value.

Key figures
20
years’
experience
€700
million
in assets under management
21
FCPI under management
24,000
clients
NewsRoom
Press release
26 March 2007
Adenclassifieds IPO successful
Adenclassifieds IPO successful
Press release
09 November 2006
The Desjonquères family sells Saverglass to Natexis Industrie, Natexis Investissement and Crédit Agricole Private Equity
The Desjonquères family sells Saverglass to Natexis Industrie, Natexis Investissement and Crédit Agricole Private Equity
Press release
30 October 2006
First capital raising transaction for SplitGames
First capital raising transaction for SplitGames
Press release
04 October 2006
Amsterdam Molecular Therapeutics BV Closes €22 Million Equity Financing
Amsterdam Molecular Therapeutics BV Closes €22 Million Equity Financing
Press release
24 April 2006
Crédit Agricole Private Equity launches CAPENERGIE, 1st FCPR dedicated to Renewable Energies
Crédit Agricole Private Equity launches CAPENERGIE, 1st FCPR dedicated to Renewable Energies
Press release
28 March 2006
PanGenetics BV agrees to a second capital increase with ABN AMRO, Index Ventures and Crédit Agricole Private Equity
PanGenetics BV agrees to a second capital increase with ABN AMRO, Index Ventures and Crédit Agricole Private Equity

Pages